Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1221706

registered interest
date	07/07/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what representations they are making to governments of other countries on the subject of drug hoarding by countries in response to the COVID-19 pandemic.
tabling member printed	Lord Kennedy of Southwark
uin	HL6563
answer	answer is ministerial correction date of answer 17/07/2020 answer text <p>The United Kingdom Government has discussed, and engaged on this issue, with other states. We are working closely with our international partners, both bilaterally and via multilateral fora, to deliver a robust global response to the COVID-19 pandemic, to reinforce the resilience of vulnerable countries; ensure access to vaccines and therapeutics; keep international supply chains open; and support the global economy.</p><p>Furthermore, as part of our concerted national efforts to respond to the COVID-19 outbreak, we are doing everything we can in this country to ensure patients continue to access safe and effective medicines. We are working closely with the pharmaceutical industry, the National Health Service and others in the supply chain to help ensure patients can access the medicines they need, and precautions are in place to reduce the likelihood of future shortages.</p> answering member printed Lord Bethell question first answered 17/07/2020 10:11:13 answering member 4708 label Biography information for Lord Bethell
tabling member	4153 label Biography information for Lord Kennedy of Southwark

1220752

registered interest
date	06/07/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	European Centre for Disease Prevention and Control
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the UK's future relationship with the European Centre for Disease Control after the transition period of the UK's departure from the EU.
tabling member printed	Lord Empey
uin	HL6444
answer	answer is ministerial correction date of answer 17/07/2020 answer text <p>As set out in the United Kingdom’s approach to negotiations with the European Union published on 27 February, the UK is ready to discuss how our citizens can be kept safe and benefit from continued international cooperation on health security following the end of the transition period, where it is in our mutual interest. The detail of the UK’s future relationship with the EU on health security is subject to the outcome of the ongoing negotiations. We welcome the discussions we have had so far on the scope of cooperation in this area and welcome continued talks going forwards.</p> answering member printed Lord Bethell question first answered 17/07/2020 12:54:43 answering member 4708 label Biography information for Lord Bethell
tabling member	4216 label Biography information for Lord Empey

1220785

registered interest
date	06/07/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medicines and Medical Devices Bill
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what discussions they have had with representatives of the medicine and medical device supply sector about planning for the implementation of any regulatory changes resulting from the enactment of the Medicines and Medical Devices Bill.
tabling member printed	Baroness Masham of Ilton
uin	HL6498
answer	answer is ministerial correction date of answer 17/07/2020 answer text <p>Departmental Ministers meet with the life sciences sector to discuss a range of issues. Officials in the Department have held discussions with a range of stakeholders, including representatives of the medicine and medical device supply sector, about the Medicines and Medical Devices Bill. As the Bill is primarily an enabling Bill, discussions with stakeholders on aspects of future regulatory change have been limited, as the details of proposed changes are still under development.</p><p>The Bill requires that consultation takes place, prior to the making of regulations in Parts 1, 2 and 3 of the Bill and this will include key stakeholders from the medicine and medical device supply sector.</p> answering member printed Lord Bethell question first answered 17/07/2020 12:55:36 answering member 4708 label Biography information for Lord Bethell
tabling member	1850 label Biography information for Baroness Masham of Ilton

1220836

registered interest
date	06/07/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Ethnic Groups
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they are taking, if any, to encourage greater BAME representation in COVID-19 research projects and clinical trials.
tabling member printed	Lord Taylor of Warwick
uin	HL6529
answer	answer is ministerial correction date of answer 17/07/2020 answer text <p>The Department, through the National Institute for Health Research (NIHR), is working in partnership with the Centre for Black and Minority Ethnic Health in Leicester to ensure that black, Asian and minority ethnic communities have the information they need to take part and stay informed about COVID-19 research. It is also actively supporting researchers to tackle the barriers that might stop some communities participating.</p> answering member printed Lord Bethell question first answered 17/07/2020 12:40:11 answering member 4708 label Biography information for Lord Bethell
tabling member	1796 label Biography information for Lord Taylor of Warwick

1220849

registered interest
date	06/07/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Records: Data Protection
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether notices issued under the Health Service (Control of Patient Information) Regulations 2002 in March cover the release of patient identifiable information to local public health teams; and if so, which (1) legal, or (2) policy, provisions prevent local directors of public health from receiving such information.
tabling member printed	Lord Freyberg
uin	HL6451
answer	answer is ministerial correction date of answer 17/07/2020 answer text <p>It is of vital importance that the health and care sector is able to access the data it needs to respond to COVID-19. A Control of Patient Information Notice was issued to require a range of organisations to share and process data for COVID-19 purposes. This should include sharing data with public health teams responding to COVID-19.</p><p> </p><p>The Notice only applies to data processed for COVID-19 purposes and organisations must also meet other regulatory and legal requirements such as the General Data Protection Regulation.</p><p> </p><p>Public Health England is making available to all local authorities information on positive tests</p><p>for COVID-19. Public Health England also routinely shares personal data with local authorities to manage and control local clusters and outbreaks of certain infectious diseases.</p> answering member printed Lord Bethell question first answered 17/07/2020 12:39:21 answering member 4708 label Biography information for Lord Bethell
tabling member	2593 label Biography information for Lord Freyberg

1220850

registered interest
date	06/07/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Records: Data Protection
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether the Data Protection Impact Assessment for the NHS COVID-19 Data Store published on 5 June covers the release of patient identifiable information to local public health teams; and if so, which (1) legal, or (2) policy, provisions prevent local directors of public health from receiving such information.
tabling member printed	Lord Freyberg
uin	HL6452
answer	answer is ministerial correction date of answer 17/07/2020 answer text <p>The COVID-19 Data Store does not hold patient identifiable data, as all data is de-identified (pseudonymised) in line with Information Commissioner’s Office (ICO) guidance and best practice, prior to being imported to the database. Therefore, the release of patient identifiable information to local public health teams, via the COVID-19 Data Store, is not possible.</p><p>NHS England is the data controller for all data held within the COVID-19 data store and ensures (via contractual arrangements) that data storage and processes are fully compliant with legislation and best practice.</p> answering member printed Lord Bethell question first answered 17/07/2020 12:19:55 answering member 4708 label Biography information for Lord Bethell
tabling member	2593 label Biography information for Lord Freyberg

1220851

registered interest
date	06/07/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Infrastructure and Projects Authority: Contact Tracing
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether the Infrastructure and Projects Authority (1) has been, or (2) will be, involved in the NHS Test and Trace programme.
tabling member printed	Lord Freyberg
uin	HL6453
answer	answer is ministerial correction date of answer 17/07/2020 answer text <p>The Infrastructure and Projects Authority (IPA) has been and continues to be involved with the NHS Test and Trace Programme. IPA provided assurance at the outset and has since supported independent peer reviews. IPA will continue to be involved by providing advice and support.</p> answering member printed Lord Bethell question first answered 17/07/2020 12:55:00 answering member 4708 label Biography information for Lord Bethell
tabling member	2593 label Biography information for Lord Freyberg

1220954

registered interest
date	06/07/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Multiple Sclerosis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will ask the National Institute for Health and Care Excellence to review the evidence behind its initial decision to reject siponimod for routine use to treat active secondary multiple sclerosis.
tabling member constituency	Dundee West
tabling member printed	Chris Law
uin	69582
answer	answer is ministerial correction date of answer 17/07/2020 answer text <p>The National Institute for Health and Care Excellence (NICE) follows established methods and processes when developing its technology appraisals guidance and only publishes final guidance on the use of a drug after careful consideration of the evidence and consultation with stakeholders.</p><p>The appraisal consultation document (ACD) on siponimod for treating secondary progressive multiple sclerosis is draft guidance and is currently subject to public consultation, allowing stakeholders and individuals to comment on the draft guidance so that their views can be taken into account. The ACD is not NICE's final guidance on a technology and the recommendations may change after consultation.</p><p>The consultation has been running from 25 June to 5pm on 23 July 2020. The consultation can be found at the following link:</p><p><a href="https://www.nice.org.uk/guidance/indevelopment/gid-ta10436/consultation/html-content-2" target="_blank">https://www.nice.org.uk/guidance/indevelopment/gid-ta10436/consultation/html-content-2</a></p><p><strong> </strong></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 17/07/2020 09:58:22 answering member 4380 label Biography information for Jo Churchill previous answer version 36164 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
tabling member	4403 label Biography information for Chris Law

1220535

registered interest
date	03/07/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has been made of the effect of the suspension of Part IX of the NHS England and Wales Drug Tariff on patient access to the latest health (a) technologies and (b) innovations.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	68706
answer	answer is ministerial correction date of answer 17/07/2020 answer text <p>The assessment of new and pending applications to the Drug Tariff has been suspended temporarily, to manage staff resource during the COVID-19 pandemic.</p><p>The Government has made no assessment on the impact of patient access to technologies or innovations during the suspension of the Part IX application process. Patient access to products already listed in Part IX is unaffected by the pause.</p><p>This suspension is reviewed regularly to inform when the assessment process will resume.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 17/07/2020 10:05:20 answering member 4380 label Biography information for Jo Churchill
tabling member	4131 label Biography information for Jim Shannon

1220672

registered interest
date	03/07/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Smoking
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps Public Health England is taking to enforce the ban on menthol cigarettes.
tabling member constituency	Nottingham North
tabling member printed	Alex Norris
uin	68784
answer	answer is ministerial correction date of answer 17/07/2020 answer text <p>The ban on characterising flavours such as menthol in cigarettes came into force on 20 May 2020. In advance of the ban, several tobacco companies launched new brands marketed at menthol smokers.</p><p>Public Health England is the Competent Authority under the Tobacco and Related Products Regulations 2016 responsible for testing and receiving notifications of tobacco products.</p><p>If any products are tested and found to be in breach of the United Kingdom regulations, then they will be removed from the list of notified products for sale.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 17/07/2020 13:55:35 answering member 4380 label Biography information for Jo Churchill previous answer version 35818 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
tabling member	4641 label Biography information for Alex Norris